Multiple Culprit Coronary Artery Thrombosis in a Patient with Coronary Ectasia

Bruno da Silva Matte1, Gustavo Neves de Araujo1, Felipe Homem Valle1

  • 1Hospital de Clínicas de Porto Alegre, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil.

Insights

This case study details a rare ST-elevation myocardial infarction (STEMI) caused by simultaneous occlusions in two coronary arteries of a patient with coronary ectasia. Aspiration thrombectomy proved valuable despite lacking proven benefits in trials.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Biology

Background:

  • Coronary ectasia, a condition characterized by abnormal dilation of coronary arteries, presents unique challenges in managing ischemic heart disease.
  • Percutaneous coronary angioplasty with bare metal stent implantation is a common intervention for coronary artery disease.
  • Very late stent thrombosis (VLST) is a rare but serious complication occurring long after stent placement.

Observation:

  • A patient with known coronary ectasia experienced ST-elevation myocardial infarction (STEMI) due to simultaneous acute occlusions in two major coronary arteries.
  • The patient had a history of percutaneous coronary angioplasty with bare metal stent implantation in both affected vessels.
  • No concomitant embolic sources were identified as a cause for the occlusions.

Findings:

  • Simultaneous acute coronary artery occlusions in a patient with coronary ectasia, potentially triggered by very late stent thrombosis in one vessel leading to events in another.
  • Aspiration thrombectomy, while not universally proven beneficial in ST-elevation myocardial infarction (STEMI) randomized trials, was highly effective in this specific case.
  • The case highlights a potential link between coronary ectasia, chronic inflammation, and heightened platelet activity contributing to plaque disruption and acute coronary events.

Implications:

  • This case underscores the complex interplay between coronary ectasia, stent-related complications, and acute myocardial infarction.
  • It suggests that aspiration thrombectomy may have a role in select complex ST-elevation myocardial infarction (STEMI) cases, particularly those involving stent thrombosis.
  • Further research into the prothrombotic mechanisms associated with coronary ectasia and chronic inflammation is warranted to optimize treatment strategies.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
510
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
298
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
411
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
728
Coronary Circulation01:21

Coronary Circulation

The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
7.4K